Juan M. Sepulveda

Hospital Universitario 12 de Octubre

Disclosure: NO DISCLOSURE DATA

Presentation(s):

• ACTR-33 - Infigratinib (BGJ398) in patients with recurrent gliomas with fibroblast growth factor receptor (FGFR) alterations: a multicenter phase II study

  Saturday, November 23
  5:00 PM – 7:00 PM

• ATIM-47 - Nivolumab vs bevacizumab in patients with recurrent glioblastoma: exploratory analysis of MGMT methylation status and baseline corticosteroid use

  Sunday, November 24
  9:05 AM – 9:15 AM